…
Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, production, marketing, processing, packaging, and distribution of dairy and related products, and nutrition products. It operates through the Dairy and Related Products, and Nutrition Products segments. The company offers cow and goat-based milk formula products for infants. It also engages in the marketing and distribution of goat milk nutrition products; manufacturing and distribution of cheese related products; research and development, distribution, manufacturing, and sale of probiotic products, and related fermentation-related products; and provision of financing services. The company operates in the People's Republic of China, Europe, Southeast Asia, Australia, the Middle East, North and South America, and internationally. Ausnutria Dairy Corporation Ltd was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd is a subsidiary of HongKong Jingang Trade Holding Company Limited.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Ausnutria Dairy Corporation Ltd develops, manufactures and sells dairy nutritional products, including infant and specialty goat-milk formulas under brands such as Kabrita for China and export markets. Long-term growth drivers include rising demand for premium infant and specialty nutrition, brand strength in goat-milk segments, and expansion of cross-border distribution that may benefit from higher consumer spending.
Key risks include regulatory and policy changes in core markets, intense competition from larger dairy groups, dependence on China for a substantial share of revenue, and exposure to supply-chain or food-safety disruptions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 165.18M | 312.51M | 201.80M | 251.28M | 1233.65M |
| Minority interest | -11.58M | -11.22M | 5.53M | 28.18M | 38.04M |
| Net income | 172.93M | 235.97M | 174.39M | 216.53M | 1040.26M |
| Selling general administrative | 2572.52M | 550.05M | 535.41M | 604.22M | 706.90M |
| Selling and marketing expenses | - | 2077.25M | 1907.97M | 2167.16M | 2415.49M |
| Gross profit | 2818.52M | 3107.91M | 2852.55M | 3392.80M | 4470.73M |
| Reconciled depreciation | 341.37M | 281.10M | 250.67M | 256.47M | 277.05M |
| Ebit | 209.69M | 364.16M | 252.72M | 300.45M | 1252.40M |
| Ebitda | 537.18M | 645.26M | 503.39M | 556.93M | 1529.46M |
| Depreciation and amortization | 327.48M | 281.10M | 250.67M | 256.47M | 277.05M |
| Operating income | 209.69M | 381.71M | 281.68M | 274.67M | 1252.40M |
| Other operating expenses | 7085.03M | 7020.73M | 7100.33M | 7343.64M | 7484.26M |
| Interest expense | 43.82M | 51.64M | 50.92M | 21.75M | 18.85M |
| Tax provision | -19.53M | 65.32M | 32.95M | 62.93M | 231.43M |
| Interest income | 37.83M | 37.44M | 35.71M | 38.19M | 28.10M |
| Net interest income | -7.15M | -14.20M | -15.21M | 16.44M | 9.24M |
| Income tax expense | -19.03M | 65.32M | 32.95M | 62.93M | 231.43M |
| Total revenue | 7294.72M | 7402.44M | 7382.01M | 7795.51M | 8873.27M |
| Total operating expenses | 2608.83M | 2726.20M | 2570.88M | 2940.94M | 3081.72M |
| Cost of revenue | 4476.20M | 4294.53M | 4529.46M | 4402.71M | 4402.54M |
| Total other income expense net | -44.52M | -69.19M | -79.87M | -23.39M | -18.75M |
| Net income from continuing ops | 189.08M | 247.19M | 168.86M | 188.34M | 1002.23M |
| Net income applicable to common shares | - | - | - | 216.53M | 1040.26M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 10260.88M | 9662.15M | 10033.76M | 9796.09M | 9514.21M |
| Intangible assets | 472.56M | 501.09M | 508.37M | 472.05M | 420.98M |
| Other current assets | 230.13M | 93.81M | 362.99M | 125.25M | 360.70M |
| Total liab | 4171.39M | 3878.67M | 4284.56M | 4231.04M | 4020.56M |
| Total stockholder equity | 6029.74M | 5721.60M | 5693.47M | 5646.57M | 5538.54M |
| Other current liab | 634.69M | 810.10M | 1054.47M | 1948.76M | 2170.39M |
| Common stock | 154.12M | 154.17M | 154.23M | 156.06M | 149.49M |
| Capital stock | 154.04M | 154.17M | 154.23M | 156.06M | 149.49M |
| Retained earnings | 4763.89M | 4595.39M | 4539.77M | - | 4708.22M |
| Other liab | - | - | - | 162.04M | 141.17M |
| Good will | 393.51M | 368.06M | 192.22M | 102.32M | 258.69M |
| Other assets | 0.00M | - | - | 673.12M | 516.15M |
| Cash | 909.95M | 1214.70M | 2043.31M | 1861.86M | 2262.19M |
| Total current liabilities | 3926.85M | 3626.20M | 4090.26M | 3600.61M | 3316.31M |
| Current deferred revenue | 227.52M | - | -16.62M | - | - |
| Net debt | 1711.27M | 1037.69M | 372.29M | -301.42M | -959.17M |
| Short term debt | 2526.65M | 2162.22M | 2394.57M | 1092.05M | 739.94M |
| Short long term debt | 2508.74M | 2137.72M | 2377.95M | 1021.63M | 687.10M |
| Short long term debt total | 2621.22M | 2252.40M | 2415.60M | 1560.44M | 1303.02M |
| Other stockholder equity | 2811.99M | 972.04M | 999.47M | 5490.51M | 5389.06M |
| Property plant equipment | - | - | - | 2793.78M | 2120.14M |
| Total current assets | 3916.72M | 4397.94M | 5080.86M | 5362.45M | 5632.33M |
| Net tangible assets | - | - | - | 5072.20M | 4858.87M |
| Short term investments | 21.79M | 206.22M | - | 6.81M | - |
| Net receivables | 772.79M | 952.96M | 590.86M | 621.06M | 602.32M |
| Long term debt | - | - | 0.00M | 443.98M | 490.47M |
| Inventory | 1982.06M | 1930.25M | 2089.41M | 2226.74M | 2198.47M |
| Accounts payable | 537.98M | 533.95M | 516.96M | 559.81M | 405.98M |
| Accumulated other comprehensive income | -1700.26M | - | 5539.24M | - | - |
| Non currrent assets other | 54.31M | 407.24M | 584.25M | 474.14M | 827.03M |
| Non current assets total | 6344.15M | 5264.20M | 4952.89M | 4433.64M | 3881.88M |
| Capital lease obligations | 111.16M | 114.68M | 37.65M | 94.82M | 125.45M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | -498.85M | -899.16M | -740.92M | -723.98M | -7.00M |
| Change to liabilities | - | - | - | 151.08M | 29.33M |
| Total cashflows from investing activities | -702.84M | -899.16M | -740.92M | -723.98M | -606.57M |
| Net borrowings | 164.19M | -146.11M | 825.90M | 260.79M | 342.76M |
| Total cash from financing activities | 22.87M | -273.59M | 682.45M | 664.11M | -34.09M |
| Change to operating activities | - | - | - | - | -312.03M |
| Net income | 172.93M | 312.51M | 201.80M | 251.28M | 1233.65M |
| Change in cash | -262.14M | -822.90M | 175.74M | -400.33M | 404.67M |
| Begin period cash flow | 1172.09M | 2037.60M | 1861.86M | 2262.19M | 1857.52M |
| End period cash flow | 909.95M | 1214.70M | 2037.60M | 1861.86M | 2262.19M |
| Total cash from operating activities | 362.82M | 299.37M | 224.71M | -357.54M | 1071.32M |
| Issuance of capital stock | - | - | 0.00M | 739.02M | 20.94M |
| Depreciation | 327.48M | 281.10M | 250.67M | 256.47M | 277.05M |
| Other cashflows from investing activities | 0.16M | -5.42M | -112.26M | - | -43.17M |
| Dividends paid | 94.64M | 80.64M | 98.46M | -430.18M | -388.16M |
| Change to inventory | 2.23M | 31.22M | -41.93M | -234.18M | -224.30M |
| Change to account receivables | -44.56M | -29.42M | 104.59M | - | -71.96M |
| Sale purchase of stock | -2.41M | -0.98M | 0.00M | -36.40M | 953.63M |
| Other cashflows from financing activities | -40.03M | -45.86M | 37.02M | 920.44M | 949.35M |
| Change to netincome | - | - | - | - | 332.96M |
| Capital expenditures | 209.08M | 385.69M | 684.03M | 704.54M | 556.39M |
| Change in working capital | -114.13M | -341.50M | -453.69M | -1129.70M | -578.96M |
| Stock based compensation | - | - | - | 0.00M | 10.86M |
| Other non cash items | -23.45M | 47.26M | 225.94M | 264.41M | 128.72M |
| Free cash flow | 153.74M | -86.32M | -459.31M | -1062.08M | 514.93M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AUDYF Ausnutria Dairy Corporation Ltd |
- -% |
0.36 | 36.00 | - | 0.09 | 0.72 | 0.48 | 6.53 |
| NSRGF Nestle SA |
-0.36 0.37% |
98.24 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
2.29 2.29% |
102.45 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
0.31 2.15% |
14.75 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
69.76 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Ausnutria Dairy Corporation Ltd, an investment holding company, primarily engages in the research and development, production, marketing, processing, packaging, and distribution of dairy and related products, and nutrition products. It operates through the Dairy and Related Products, and Nutrition Products segments. The company offers cow and goat-based milk formula products for infants. It also engages in the marketing and distribution of goat milk nutrition products; manufacturing and distribution of cheese related products; research and development, distribution, manufacturing, and sale of probiotic products, and related fermentation-related products; and provision of financing services. The company operates in the People's Republic of China, Europe, Southeast Asia, Australia, the Middle East, North and South America, and internationally. Ausnutria Dairy Corporation Ltd was founded in 2003 and is based in Sheung Wan, Hong Kong. Ausnutria Dairy Corporation Ltd is a subsidiary of HongKong Jingang Trade Holding Company Limited.
| Name | Title | Year Born |
|---|---|---|
| Mr. Weibin Yan | Co-Founder & Exec. Chairman | 1966 |
| Mr. Bartle van der Meer | CEO & Exec. Director | 1946 |
| Ms. Siu Hung Ng | Exec. Director | 1969 |
| Mr. Wei Hua Wong | CFO & Company Sec. | 1972 |
| Ms. Tracy Sun | Head of Investor Relations | NA |
| Mr. Zhiyong Dai | Vice Chairman and Chief Quality Officer - Ausnutria Institution of Food & Nutrition | 1975 |
| Mr. Yuehui Liu | Chief Supervisor | 1963 |
| Mr. Shenhui Deng | Chief Operation Officer of Group - PRC Region | 1974 |
| Dr. Alfred Haandrikman | Global Chief Scientific Officer of Ausnutria B.V. | 1958 |
| Mr. Zhijian Ren | CEO & Executive Director | 1975 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.